US experts to scrutinise MoM hips in two-day FDA meeting
This article was originally published in SRA
The US Food and Drug Administration will be holding a two-day meeting in June to assess the risks and benefits of metal-on-metal (MoM) hip systems and evaluate potential guidelines for patients and practitioners on the use and management of these devices1,2.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.